Professor Zhongchao Han has been engaged in the research work of hematology, stem cells biology & engineering technology for many years. Altogether, he has published over 500 academic theses, among which 250 English theses appear on international journals. He is the chief editor/ editor of six English academic monographs and eight Chinese academic monographs. In the Elsevier International Assessment, he was selected for China's high-income laborer list for 5 consecutive years. (2015-2019). Professor Zhongchao Han and his team has won more than 20 national and international prizes for the scientific and technological work they accomplished.

Taesung Park received his B.S. and M.S. degrees in Statistics from Seoul National University (SNU), Korea in 1984 and 1986 respectively and received his Ph.D. degree in Biostatistics from the University of Michigan in 1990. From Aug. 1991 to Aug. 1992, he worked as a visiting scientist at the NIH, USA. From Sep. 2002 to Aug. 2003, he was a visiting professor at the University of Pittsburgh. From Sep. 2009 to Aug. 2010, he was a visiting professor in Department of Biostatistics at the University of Washington. He served as the chair of the bioinformatics Program, from Apr. 2005 to Mar. 2008 and the chair of department of statistics of SNU from Sep. 2007 and Aug. 2009. He is currently the Professor and Director of the Bioinformatics and Biostatistics Lab. at the Dept. of Statistics, SNU. He has published over 500 papers. Overall, his works have received more than 21002 Citations. His i10-index is 199, and h-index is 50 (reference Google Scholar).

Prof. Pietro Morasso is currently a Senior Researcher at the Department of Robotics, Brain and Cognitive Sciences at the Italian Institute of Technology. After a Master’s degree in Electronic Engineering, from Genoa University, Italy, in 1968, he was Visiting Professor at MIT until 1978 in the lab of Prof. Emilio Bizzi, before returning to Genoa, where he served as Full Professor in Biomedical Engineering until 2009, when he joined the newly established Italian Institute of Technology.

Awards: Marconi Co. Ltd Chelmsford UK (1968); Fullbright fellowship (1973); NATO fellowship (1978); Honeywell HUSPI Prize (1984); ZIF fellowship, Bielefeld, Germany (1999); Commander of the Order of Merit of the Italian Republic (2000); JSPS fellowship, Tokyo, Japan (2009).

He is the author of six books and over 400 publications in the field of motor neuroscience and humanoid robotics, with an h-index of 52, i10 index of 162, and 15050 citations (Google Scholar).

Dr. Li is an Associate Professor in the Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University, and is a fellow of the American Association of Physicists in Medicine. He serves as the Chief Proton Physicist of the Johns Hopkins Proton Therapy Center, located at the Sibley Memorial Hospital, Washington DC. He completed his Ph.D. Degree in Electrical and Computer Engineering at the University of Virginia, Charlottesville, VA in 2006, and received postdoctoral fellowship and therapeutic medical physics residency trainings at the University of Texas MD Anderson Cancer Center. He was a faculty at the University of Texas MD Anderson Cancer Center from 2010-2019. His research interests include proton therapy physics, motion management in radiotherapy, global health, and AI application in radiation oncology. He has published over 70 scientific papers in peer-reviewed academic journals and authored 9 book chapters.

Dr. Mao received his PhD (Physical Chemistry) at the National Center for Nanoscience and Technology, Chinese Academy of Sciences in 2010. He then worked as postdoc in the labs of Profs. Drs. Ted and Valina Dawson at the Institute for Cell Engineering, Department of Neurology, Johns Hopkins School of Medicine (JHSOM) during 2010-2016. After postdoctoral fellowship, he worked as Assistant Professor in 2017 and became Associate Professor in 2021 at JHSOM. He has published more than 50 research articles in many high-impact journals (Science, Nature, Nature Medicine, PNAS, Nature Comm, Nano Today) focusing on pathogenic protein cell-to-cell spreading.

Dr. Andrea Kwa graduated with a degree in Pharmacy from the National University of Singapore in 1996 and received her Doctor of Pharmacy Degree from the Albany College of Pharmacy and Health Sciences in New York in 2006. She then completed a two-year postdoctoral research fellowship at the University of Pittsburgh’s Division of Infectious Diseases, where she researched anti-fungal resistance and molecular diagnostics. Dr Kwa is currently a Pharmacy Clinician Scientist and Assistant Director, Pharmacy (Research), at the Singapore General Hospital. She is also a faculty member of the Emerging Infectious Diseases program at Duke-NUS Medical School. Dr. Kwa specializes in critical care medicine, infectious diseases and antimicrobial resistance research. She helms a laboratory studying antimicrobial pharmacodynamics/pharmacokinetics and resistance. She also performs health services research involving antimicrobial stewardships, risk factors and outcomes of resistant infections. Dr. Kwa has authored more than 60 publications and is a reviewer for many scientific journals.

Prof. Mario Allegra studied Chemistry and Pharmaceutical Technologies at the University of Palermo, Italy, and graduated as Pharm.D. in 1997. He then joined the research group of Prof. Perretti at the Department of Biochemical Pharmacology, Queen Mary’s University of London. Since 2000, he has been working at the University of Palermo, where he received his Ph.D. in molecular medicine and now holds the position of Associate Professor of Biochemistry. His research interests cover the role of phytochemicals in oxidative stress-dependent inflammatory conditions. He has published more than 60 research articles in SCI(E) journals, with 4183 citations and anh-index of 28.

Patricio Yankilevich received his Ph.D.in Molecular Biology from Universidad Autónoma de Madrid in 2011 and MSc.in Bioinformatics&Neuroinformatics from University of Edinburgh in 2003 respectively.In his Ph.D.thesis he further research on gene network inference based on the consensus of multiple graphical probabilistic models which integrate genetic expression and annotation databases.Currently,he is a Bioinformatics Group Leader at Instituto de Investigación en Biomedicina de Buenos Aires–CONICET–Instituto Partner de la Sociedad Max Planck(IBioBA-CONICET-MPSP).Before this position he was a Product Manager at Integromics SL.and as Researcher at the Spanish National Center of Biotechnology(CNB).In Argentina I worked as Bioinformatics Laboratory Director at the Instituto de Agrobiotecnología de Rosario,and previously at BioSidus S.A.where he was the Bioinformatics unit P.I.,and in Madrid at the Spanish National Cancer Research Centre(CNIO,Madrid)as Staff Scientist at the Bioinformatics unit.His specialties include Broad Bioinformatics knowledge in Genomics,Proteomics and Systems Biology-Biological Networks-Gene expression analysis-Sequence analysis-NGS.

Wolfgang Orthuber works as an orthodontist and mathematician at the University Hospital Schleswig-Holstein (UKSH). More than a decade ago he started to research objectivity and comparison of information (first in medicine, then in general). The basic analysis showed that any information is a selection from an ordered set or "domain" that must be the same for the sender and all receivers of the information. This can be broadly generalized: we can uniformly and efficiently define the domain of information by defining sequence of numbers online that are relevant to the application of interest. Wolfgang Orthuber also has developed the numerical search engine http://numericsearch.com to demonstrate the precise findability of such information. The global application of the concept would have significant economic, technical and scientific potential.

Dr. Junyi Liang obtained PhD from the Chinese University of Nanking. His work there has been described as “unique” by globally-renowned biosensor developer. And In 2014, he joined the Ishikawa Prefecture’s Bio-AFM center directed by Prof. Toshio Ando, he took part in one of Japan’s national grants back then – the JST/CREST, where he carried out fast-scanning atomic force microscopy work. He then left Japan for the states and participated in NIH grant R01HL122827 in the creation of optical biosensor mice for longitudinal studies of vascular function at UMB. After these stints in basic science research, he helped form and conduct collaboration between a Korean pharmaceutical company and Akron University, with the potential commercialization of novel compounds as cancer drugs on the horizon. As of now in the month or so leading up to this conference, he is being recruited to Cleveland Clinic and on way to onboard the clinic’s Lerner Research Institute as a senior technologist, continuing his endeavor in the greater basic science.

Dr. Murtaza Hasan has completed his PhD in in Biochemical Science from Beijing Institute of Technology in 2014 and Post Doctorate in 2016 under of funding of Peking University Beijing China. Dr. Murtaza Hasan has vast experience in Teaching and Research in different institute at national and international level. His research area is green synthesis of nanoparticles and their biomedical application, Synthesis of Nano-Biofertilizers and their impacts on crops, Surface coating of nanoparticles and harvesting key biomarker from cancer serum. Nano-Proteomics and Nano-biosensor. He has published more than 80 international publications with more than 300 impact factors. He has supervised 42 MS research student to be graduated from Biochemistry and Biotechnology Department. Currently, there are 5 PhD and 7 MS students are working under his supervision.